Search

everythinglearnresearchcommunity

for

Search:↓

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Early identification of lupus through skin signs and blood tests is crucial in India.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

The model and estimator can predict drug exposure in kidney transplant patients well.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Stress affects skin health and emotional well-being should be considered in skin disease treatment.

Skin problems are common in people with diabetes and controlling blood sugar can reduce these issues.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.